Hapi (Nile god)

Masimo Centroid® Receives Innovative Technology Designation from Vizient

Retrieved on: 
Wednesday, February 15, 2023
Apps, Applications, Mobile, Wireless, Technology, Health Technology, Software, Hardware, Managed Care, Health, Data Management, Consumer Electronics, Automation, Hapi (Nile god), Patient safety, Hospital, Pressure, HACS, Safety, Algorithm, Orientation, Patient, AUC, The Queen's Award for Enterprise: Innovation (Technology) (2003), Respiration, Suretrack Contracts Services, Risk, Connectivity, Multimedia, HAC, MASI, Nursing, Centroid, Masimo, Vizient, Inc.

Masimo exhibited Centroid in combination with the Masimo Root® Patient Monitoring and Connectivity platform at the Vizient Innovative Technology Exchange held in Dallas last October.

Key Points: 
  • Masimo exhibited Centroid in combination with the Masimo Root® Patient Monitoring and Connectivity platform at the Vizient Innovative Technology Exchange held in Dallas last October.
  • Bilal Muhsin, Chief Operating Officer of Masimo Healthcare, said, “We are honored that Vizient has selected Centroid for its Innovative Technology designation.
  • Through its Innovative Technology Program , Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System

Retrieved on: 
Monday, January 30, 2023
Safety, The Queen's Award for Enterprise: Innovation (Technology) (2002), INT, Turning, DOM events, Conference, Use, Health, NYSE, Hapi (Nile god), International Reporting Project, LSE, Contraindication, Hospital, Patient safety, Treatment, Albanian American Organization Chameria, Poster, Vizient, Inc., Patient, US Commercial Real Estate Index, Senior, SNN, Hospital-acquired infection, Pharmaceutical industry, Nursing, Medical device, Critical care

LONDON, Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its LEAF Patient Monitoring System has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the United States. Smith+Nephew exhibited the LEAF Patient Monitoring System at the Vizient Innovative Technology Exchange on October 17th in Dallas, Texas.

Key Points: 
  • LONDON, Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its LEAF Patient Monitoring System has received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the United States.
  • Smith+Nephew exhibited the LEAF Patient Monitoring System at the Vizient Innovative Technology Exchange on October 17th in Dallas, Texas.
  • "We will not settle until we've solved this challenge and are excited for the role our LEAF Patient Monitoring System will play - fast becoming a standard of patient care in the U.S. and reducing facility costs."
  • Schutt SC, Tarver C, Pezzani M. Pilot study: Assessing the effect of continual position monitoring technology on compliance with patient turning protocols.

Net Health Expands Predictive Analytics Resources for Wound Care Providers

Retrieved on: 
Thursday, July 7, 2022
FDA, Patient, Pressure, CEO, Caregiver, Health, CMS, Nursing care plan, The Carlyle Group, Industry, Compliance, Innovation, Risk, Food, Net Health, EHR, Organization, Mouth ulcer, Quality of life, Machine learning, VP, Rollcage Stage II, Food and Drug Administration Modernization Act of 1997, Injury, Event-driven architecture, Multimedia, Hapi (Nile god), Hospital, Medicine, Medical device, Health insurance

PITTSBURGH, July 7, 2022 /PRNewswire/ -- Further expanding its analytics capabilities and leadership position within the wound care marketplace, Net Health, a provider of specialty electronic health systems and advanced healthcare analytics, today announced the addition of two new predictive analytics resources to improve clinical and operational outcomes for wound care providers.

Key Points: 
  • PITTSBURGH, July 7, 2022 /PRNewswire/ -- Further expanding its analytics capabilities and leadership position within the wound care marketplace, Net Health, a provider of specialty electronic health systems and advanced healthcare analytics, today announced the addition of two new predictive analytics resources to improve clinical and operational outcomes for wound care providers.
  • The Missed Visit Prediction indicator is available in Net Health Wound Care, one of the nation's most widely used electronic health record (EHR) platforms for wound care.
  • Both features are embedded in automated workflow processes and alert providers when risk is detected, enabling providers to intervene in real-time.
  • "Predictive analytics is transforming every aspect of healthcare and establishing new industry benchmarks for better outcomes, cost savings and other efficiencies every day," said Josh Pickus, CEO of Net Health.

Net Health's Tissue Analytics for Wound Care Granted Breakthrough Device Status by FDA

Retrieved on: 
Thursday, June 2, 2022
Digital health, Caregiver, Company, Health, Laika (EHR testing framework), Therapy, LLC, TA, CEO, Organization, Solution, Multimedia, FDA, EHR, MCRA, Patient, Hospital, Technology, Net Health, Compliance, Hapi (Nile god), Agency, Diagnosis, The Carlyle Group, Public health, View, Breakthrough, Medical device, Medical imaging, Software, History

PITTSBURGH, June 2, 2022 /PRNewswire/ -- Net Health, a provider of specialty electronic healthcare record (EHR) and predictive analytics software, announced today that Tissue Analytics, the company's AI-powered wound imaging and analysis software, has been granted Breakthrough Device Status by the U.S. Food & Drug Administration (FDA). Tissue Analytics received the rare designation because of its novel diagnostic algorithms. The Company believes the FDA designation represents the first time an EHR company has been granted such designation.

Key Points: 
  • PITTSBURGH, June 2, 2022 /PRNewswire/ -- Net Health, a provider of specialty electronic healthcare record (EHR) and predictive analytics software, announced today that Tissue Analytics , the company's AI-powered wound imaging and analysis software,has been granted Breakthrough Device Status by the U.S. Food & Drug Administration (FDA).
  • Breakthrough Status is not granted solely on the severity of the device's applicable condition.
  • In granting the Breakthrough Device Status, the FDA recognized that the software could help wound care providers improve care by standardizing the diagnosis and care process of triaging patients with chronic, non-healing wounds with poor healing trajectories.
  • "The FDA's breakthrough designation acknowledges that Tissue Analytics is a first-of-its-kind device in Wound Care.

Temple University Hospital Adopts Masimo Centroid™

Retrieved on: 
Monday, February 7, 2022
Software, Nursing, Health, Medical Devices, Hospitals, Technology, University, Education, Connectivity, Carboxyhemoglobin, Sale, Radius, Temple Health, Gateway, RN, Health care, Mouth ulcer, Retinopathy, Premature, Motion, Iloilo, Vizient, Inc., Pressure, MASI, Solution, Bed, FDA, ICU, Temple University Hospital, DNP, Ulcer, National, U.S. News & World Report, NASDAQ, News, HACS, Incidence, Risk, Technology, Patient, Safety net, RD, Rx, Health, PVI, Multimedia, Ori, Automation, Respiration, Methemoglobin, Orientation, Hospital, Trauma, University, Hapi (Nile god), CEO, Movement, HAC, Oxygen saturation (medicine), Medical imaging, Health insurance, Centroid, Masimo, Temple University Hospital, MASIMO, TEMPLE UNIVERSITY HOSPITAL

Masimo (NASDAQ: MASI) and Temple Health today announced that Temple University Hospital (TUH) , a 722-bed academic medical center located in Philadelphia, is expanding its use of Masimo technologies with Centroid, an advanced wireless patient position, orientation, activity, and respiration rate sensor, at 100 beds across its ICU units.

Key Points: 
  • Masimo (NASDAQ: MASI) and Temple Health today announced that Temple University Hospital (TUH) , a 722-bed academic medical center located in Philadelphia, is expanding its use of Masimo technologies with Centroid, an advanced wireless patient position, orientation, activity, and respiration rate sensor, at 100 beds across its ICU units.
  • In addition, Centroid data can be relayed via the Masimo Hospital Automation platform to Patient SafetyNet, Masimos centralized remote patient supplemental monitoring platform, and Replica, a mobile application that allows clinicians to view continuous data regardless of location.
  • With the addition of Centroid, Temple adds another key Masimo innovation to their toolkit.
  • Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation platform, and include Iris Gateway, iSirona, Patient SafetyNet, Replica, Halo ION, UniView, UniView :60, and Masimo SafetyNet.